FASN-IN-5
FASN-IN-5 (example 11), a FASN inhibitor, can be used for the research of TH17- or CSF1 -mediated disease or disorder such as cancer, immunological disorders, and obesity[1].
Product Specifications
CAS Number
1309805-49-9
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Fatty Acid Synthase (FASN)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Inflammation/Immunology; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/fasn-in-5.html
Purity
99.98
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C(C1CC1)N(CC2)C[C@@H]2CN3C(C4=CC=C(C5=CC=C(OC=C6)C6=C5)C=C4)=NC7=CN=CC=C73
Molecular Formula
C29H26N4O2
Molecular Weight
462.54
Precautions
H302, H315, H319, H335
References & Citations
[1]David S. MILLAN, et al. Methods of using fasn inhibitors. WO2017189613A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD44 Standard (DF1485), CF594 conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
Eosinophil Peroxidase (AHE-1), CF647 conjugate, 0.1mg/mL
